Skip to Main Content
Table 2—

Prevalence of metabolic syndrome in patients with and without complications

Type 1 diabetes
Type 2 diabetes
nMetabolic syndrome
nMetabolic syndrome
Absent (%)Present (%)Absent (%)Present (%)
AHA/NHLBI metabolic syndrome       
    Complication       
        None 322 76.4 23.6 4,211 34.7 65.3 
        Retinopathy 218 58.3 41.7 1,732 24.7 75.3 
        Neuropathy 123 51.2 48.8 1,115 24.5 75.5 
        Nephropathy 172 48.3 51.7 1,777 21.7 78.3 
        Cardiovascular 59 45.8 54.2 1,302 23.3 76.7 
IDF metabolic syndrome       
    Complication       
        None 322 70.8 29.2 4,211 26.9 73.1 
        Retinopathy 218 49.5 50.5 1,732 17.2 82.8 
        Neuropathy 123 44.7 55.3 1,115 18.2 81.8 
        Nephropathy 172 40.1 59.9 1,777 14.9 85.1 
        Cardiovascular 59 35.6 64.4 1,302 14.6 85.4 
Type 1 diabetes
Type 2 diabetes
nMetabolic syndrome
nMetabolic syndrome
Absent (%)Present (%)Absent (%)Present (%)
AHA/NHLBI metabolic syndrome       
    Complication       
        None 322 76.4 23.6 4,211 34.7 65.3 
        Retinopathy 218 58.3 41.7 1,732 24.7 75.3 
        Neuropathy 123 51.2 48.8 1,115 24.5 75.5 
        Nephropathy 172 48.3 51.7 1,777 21.7 78.3 
        Cardiovascular 59 45.8 54.2 1,302 23.3 76.7 
IDF metabolic syndrome       
    Complication       
        None 322 70.8 29.2 4,211 26.9 73.1 
        Retinopathy 218 49.5 50.5 1,732 17.2 82.8 
        Neuropathy 123 44.7 55.3 1,115 18.2 81.8 
        Nephropathy 172 40.1 59.9 1,777 14.9 85.1 
        Cardiovascular 59 35.6 64.4 1,302 14.6 85.4 

Total diagnosed according AHA/NHLBI and IDF criteria: type 1 diabetic patients n = 638, type 2 diabetic patients n = 7,859.

Close Modal

or Create an Account

Close Modal
Close Modal